Celgene Resubmits Multiple Sclerosis Drug NDA for FDA Approval - https://t.co/aKeLjhpYhA Managed Markets Network https://t.co/Kp3k6bBwxw
— IDRO (@IDROOhio) March 29, 2019
from Twitter https://twitter.com/IDROOhio
March 29, 2019 at 11:41AM
Friday, March 29, 2019
Celgene Resubmits Multiple Sclerosis Drug NDA for FDA Approval - https://t.co/aKeLjhpYhA Managed Markets Network https://t.co/Kp3k6bBwxw
from Twitter https://twitter.com/IDROOhio
March 29, 2019 at 11:41AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment